Gastric cancer is a leading cause of cancer-related deaths in China. Affecting more than 40% of the world's population, Helicobacter pylori is a major risk factor for gastric cancer. While previous clinical trials indicated that eradication of H. pylori could reduce gastric cancer risk, this remains to be shown using a population-based approach. We conducted a community-based, cluster-randomized, controlled, superiority intervention trial in Linqu County, China, with individuals who tested positive for H. pylori using a 13C-urea breath test randomly assigned to receiving either (1) a 10-day, quadruple anti-H. pylori treatment (comprising 20 mg of omeprazole, 750 mg of tetracycline, 400 mg of metronidazole and 300 mg of bismuth citrate) or (2) symptom alleviation treatment with a single daily dosage of omeprazole and bismuth citrate. H. pylori-negative individuals did not receive any treatment. We examined the incidence of gastric cancer as the primary outcome. A total of 180,284 eligible participants from 980 villages were enrolled over 11.8 years of follow-up, and a total of 1,035 cases of incident gastric cancer were documented. Individuals receiving anti-H. pylori therapy showed a modest reduction in gastric cancer incidence in intention-to-treat analyses (hazard ratio 0.86, 95% confidence interval 0.74-0.99), with a stronger effect observed for those having successful H. pylori eradication (hazard ratio 0.81, 95% confidence interval 0.69-0.96) than for those who failed treatment. Moderate adverse effects were reported in 1,345 participants during the 10-day treatment. We observed no severe intolerable adverse events during either treatment or follow-up. The findings suggest the potential for H. pylori mass screening and eradication as a public health policy for gastric cancer prevention. Chinese Clinical Trial Registry identifier: ChiCTR-TRC-10000979 .
- MeSH
- antibakteriální látky terapeutické užití aplikace a dávkování MeSH
- dospělí MeSH
- Helicobacter pylori * účinky léků MeSH
- infekce vyvolané Helicobacter pylori * farmakoterapie epidemiologie mikrobiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- metronidazol terapeutické užití aplikace a dávkování MeSH
- nádory žaludku * prevence a kontrola epidemiologie mikrobiologie MeSH
- omeprazol * terapeutické užití aplikace a dávkování MeSH
- organokovové sloučeniny terapeutické užití aplikace a dávkování MeSH
- senioři MeSH
- tetracyklin terapeutické užití aplikace a dávkování MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
- Geografické názvy
- Čína epidemiologie MeSH
- Názvy látek
- antibakteriální látky MeSH
- metronidazol MeSH
- omeprazol * MeSH
- organokovové sloučeniny MeSH
- tetracyklin MeSH
Photodynamic therapy (PDT) is gradually becoming an alternative method in the treatment of several diseases. Here, we investigated the role of oxygen in photodynamically treated cervical cancer cells (HeLa). The effect of PDT on HeLa cells was assessed by exposing cultured cells to disulphonated zinc phthalocyanine (ZnPcS2) and tetrasulphonated zinc tetraphenylporphyrin (ZnTPPS4). Fluorescence microscopy revealed their different localizations within the cells. ZnTPPS4 seems to be mostly limited to the cytosol and lysosomes, whereas ZnPcS2 is most likely predominantly attached to membrane structures, including plasmalemma and the mitochondrial membrane. Phototoxicity assays of PDT-treated cells carried out under different partial pressures of oxygen showed dose-dependent responses. Interestingly, ZnPcS2 was also photodynamically effective at a minimal level of oxygen, under a nitrogen atmosphere. On the other hand, hyperbaric oxygenation did not lead to a higher PDT efficiency of either photosensitizer. Although both photosensitizers can induce a significant drop in mitochondrial membrane potential, ZnPcS2 has a markedly higher effect on mitochondrial respiration that was completely blocked after two short light cycles. In conclusion, our observations suggest that PDT can be effective even in hypoxic conditions if a suitable sensitizer is chosen, such as ZnPcS2, which can inhibit mitochondrial respiration.
- Klíčová slova
- Hyperbaria, Photodynamic therapy, Photosensitizers,
- MeSH
- fotochemoterapie metody MeSH
- fotosenzibilizující látky farmakologie MeSH
- HeLa buňky MeSH
- indoly aplikace a dávkování farmakologie MeSH
- kyslík aplikace a dávkování farmakologie MeSH
- lidé MeSH
- membránový potenciál mitochondrií účinky léků MeSH
- metaloporfyriny aplikace a dávkování farmakologie MeSH
- mitochondrie účinky léků MeSH
- organokovové sloučeniny aplikace a dávkování farmakologie MeSH
- parciální tlak MeSH
- singletový kyslík analýza MeSH
- viabilita buněk účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- fotosenzibilizující látky MeSH
- indoly MeSH
- kyslík MeSH
- metaloporfyriny MeSH
- organokovové sloučeniny MeSH
- singletový kyslík MeSH
- zinc phthalocyanine disulfonate MeSH Prohlížeč
- zinc tetraphenylporphyrin MeSH Prohlížeč
BACKGROUND: The aim of this study was comparison the effectiveness of sequential and standard quadruple therapy on eradication of H. pylori infection. METHODS: This clinical trial study was conducted on 160 patients with dyspepsia or gastroduodenal ulcer. Patients were randomly divided into two groups. Group A (standard regimen) received omeprazole, amoxicillin, clarithromycin and bismuth subcitrate for 2 weeks. Group B (sequential regimen) received omeprazole and amoxicillin in 5 days and omeprazole, tinidazole and levofloxacin in 5 days. After the end of treatment regimens, 20 mg omeprazole was administered twice daily for 3 weeks. H. pylori eradication was assessed 2 months after antibiotic treatment via fecal antigen. RESULTS: Frequency of H. pylori eradication in group A and B was observed in 55 (68.8%) and 63 patients (78.8%), respectively. No significant difference was seen between two groups, regarding H. pylori eradication (p = 0.15). The most common side effects in group A, B were bitterness of mouth (63.8%) and nausea (16.2%), respectively (p H. pylori infection, higher rate of H. pylori eradication was seen in group B than group A. Thus, sequential regimen was a more appropriate regimen with fewer complications.
- Klíčová slova
- H. pylori infection, Sequential therapy, eradication, standard triple-drug therapy,
- MeSH
- amoxicilin aplikace a dávkování MeSH
- dospělí MeSH
- Helicobacter pylori MeSH
- infekce vyvolané Helicobacter pylori farmakoterapie MeSH
- klarithromycin aplikace a dávkování MeSH
- kombinovaná farmakoterapie MeSH
- levofloxacin aplikace a dávkování MeSH
- lidé středního věku MeSH
- lidé MeSH
- omeprazol aplikace a dávkování MeSH
- organokovové sloučeniny aplikace a dávkování MeSH
- senioři MeSH
- tinidazol aplikace a dávkování MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- srovnávací studie MeSH
- Názvy látek
- amoxicilin MeSH
- bismuth tripotassium dicitrate MeSH Prohlížeč
- klarithromycin MeSH
- levofloxacin MeSH
- omeprazol MeSH
- organokovové sloučeniny MeSH
- tinidazol MeSH
Obesity is characterized by accumulation of adipose tissue and is one the most important risk factors in the development of insulin resistance. Carbon monoxide-releasing (CO-releasing) molecules (CO-RMs) have been reported to improve the metabolic profile of obese mice, but the underlying mechanism remains poorly defined. Here, we show that oral administration of CORM-401 to obese mice fed a high-fat diet (HFD) resulted in a significant reduction in body weight gain, accompanied by a marked improvement in glucose homeostasis. We further unmasked an action we believe to be novel, by which CO accumulates in visceral adipose tissue and uncouples mitochondrial respiration in adipocytes, ultimately leading to a concomitant switch toward glycolysis. This was accompanied by enhanced systemic and adipose tissue insulin sensitivity, as indicated by a lower blood glucose and increased Akt phosphorylation. Our findings indicate that the transient uncoupling activity of CO elicited by repetitive administration of CORM-401 is associated with lower weight gain and increased insulin sensitivity during HFD. Thus, prototypic compounds that release CO could be investigated for developing promising insulin-sensitizing agents.
- Klíčová slova
- Adipose tissue, Bioenergetics, Diabetes, Metabolism, Therapeutics,
- MeSH
- adenosintrifosfát metabolismus MeSH
- buňky 3T3-L1 MeSH
- dieta s vysokým obsahem tuků MeSH
- hmotnostní přírůstek účinky léků MeSH
- inzulinová rezistence * MeSH
- myši inbrední C57BL MeSH
- myši obézní MeSH
- myši MeSH
- N-substituované glyciny aplikace a dávkování farmakologie MeSH
- obezita metabolismus MeSH
- organokovové sloučeniny aplikace a dávkování farmakologie MeSH
- oxid uhelnatý metabolismus MeSH
- tukové buňky účinky léků metabolismus MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- adenosintrifosfát MeSH
- CORM-401 MeSH Prohlížeč
- N-substituované glyciny MeSH
- organokovové sloučeniny MeSH
- oxid uhelnatý MeSH
BACKGROUND & AIMS: The optimal duration of bowel preparation has only been assessed for polyethylene glycol (PEG). The aim of the study was to determine the intervals for achieving a satisfactory quality/tolerability of the preparation using PEG/ascorbic acid (PEGA) and sodium picosulphate/magnesium citrate (SPMC), and to compare them with 4L of PEG. METHODS: A randomized, endoscopist-blinded, multicentre study. The 612 outpatients referred to a colonoscopy, were prepared using PEG, SPMC, PEGA. The quality, tolerability, duration of the preparation, and the interval from the end of the preparation to the colonoscopy was assessed. RESULTS: Optimum duration of the preparation was similar for both PEG and SPMC (≥7.3 vs. ≥8.8 h, overall ≥8.4 h). Optimum interval to the colonoscopy was ≤11.8 h and did not differ between preparations (PEG, PEGA ≤ 11.8, SPMC ≤ 13.3 h). These times were the only predictors for a satisfactory preparation. The tolerability depends on the product type (SPMC) only. Timing of the preparation or the other factors had no impact on tolerability. CONCLUSION: The optimum intervals for bowel preparation are identical for all preparations. Satisfactory preparation is achived at the preparation length ≥8.4 h and the time to colonoscopy ≤11.8 h.
- Klíčová slova
- Ascorbic acid, Bowel preparation, Colonoscopy, Polyethylene glycol, Sodium picosulfate,
- MeSH
- časové faktory MeSH
- citráty aplikace a dávkování MeSH
- kolonoskopie * MeSH
- kyselina askorbová aplikace a dávkování MeSH
- lidé středního věku MeSH
- lidé MeSH
- organokovové sloučeniny aplikace a dávkování MeSH
- pikoliny aplikace a dávkování MeSH
- polyethylenglykoly aplikace a dávkování MeSH
- předoperační péče metody MeSH
- purgativa aplikace a dávkování MeSH
- senioři MeSH
- spokojenost pacientů MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
- srovnávací studie MeSH
- Geografické názvy
- Česká republika MeSH
- Názvy látek
- citráty MeSH
- kyselina askorbová MeSH
- organokovové sloučeniny MeSH
- picosulfate sodium MeSH Prohlížeč
- pikoliny MeSH
- polyethylenglykoly MeSH
- purgativa MeSH
The effective drug delivery systems for cancer treatment are currently on high demand. In this paper, biological behavior of the novel hybrid copolymers based on polysaccharide glycogen were characterized. The copolymers were modified by fluorescent dyes for flow cytometry, confocal microscopy, and in vivo fluorescence imaging. Moreover, the effect of oxazoline grafts on degradation rate was examined. Intracellular localization, cytotoxicity, and internalization route of the modified copolymers were examined on HepG2 cell line. Biodistribution of copolymers was addressed by in vivo fluorescence imaging in C57BL/6 mice. Our results indicate biocompatibility, biodegradability, and non-toxicity of the glycogen-based hybrid copolymers. Copolymers were endocyted into the cytoplasm, most probably via caveolae-mediated endocytosis. Higher content of oxazoline in polymers slowed down cellular uptake. No strong colocalization of the glycogen-based probe with lysosomes was observed; thus, it seems that the modified externally administered glycogen is degraded in the same way as an endogenous glycogen. In vivo experiment showed relatively fast biodistribution and biodegradation. In conclusion, this novel nanoprobe offers unique chemical and biological attributes for its use as a novel drug delivery system that might serve as an efficient carrier for cancer therapeutics with multimodal imaging properties.
- Klíčová slova
- Cancer, Contrast agents, Drug delivery, Glycogen, Polymers,
- MeSH
- buňky Hep G2 MeSH
- endocytóza MeSH
- fluorescein-5-isothiokyanát aplikace a dávkování farmakokinetika MeSH
- fluorescenční barviva aplikace a dávkování farmakokinetika MeSH
- glykogen aplikace a dávkování farmakokinetika MeSH
- heterocyklické sloučeniny aplikace a dávkování farmakokinetika MeSH
- lidé MeSH
- myši inbrední C57BL MeSH
- nosiče léků aplikace a dávkování farmakokinetika MeSH
- organokovové sloučeniny aplikace a dávkování farmakokinetika MeSH
- polyaminy aplikace a dávkování farmakokinetika MeSH
- tkáňová distribuce MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- fluorescein-5-isothiokyanát MeSH
- fluorescenční barviva MeSH
- gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate MeSH Prohlížeč
- glykogen MeSH
- heterocyklické sloučeniny MeSH
- nosiče léků MeSH
- organokovové sloučeniny MeSH
- poly(2-methyl-2-oxazoline) MeSH Prohlížeč
- polyaminy MeSH
PURPOSE: The purpose of this study is to compare the efficacy and tolerability of polyethylene glycol (PEG) to sodium picosulfate/magnesium citrate (SPMC) and low-volume polyethylene glycol/ascorbic acid (PEGA) in a single- or split-dose regimen for colonoscopy bowel preparation. METHODS: This was a prospective, randomized, endoscopist-blinded, multicentre study. Outpatients received either PEG or SPMC or PEGA in a single or a split dose before the colonoscopy. Quality and tolerability of the preparation and complaints during preparation were recorded. RESULTS: Nine hundred seventy-three patients were analysed. Satisfactory bowel cleansing (Aronchick score 1 + 2) was more frequent when a split dose was used irrespective of the solution type (PEG 90.1 vs 68.8%, PEGA 86.0 vs 71.6%, SPMC 84.3 vs 60.2%, p < 0.001). SPMC was the best tolerated followed by PEGA (p < 0.006) and PEG as the worst (p < 0.001). Tolerability did not correlate with the regimen and amount of the solution used. Female gender is associated with a higher incidence of nausea, vomiting and pain (p < 0.029). CONCLUSIONS: Both PEG, PEGA and SPMC are fully comparable in terms of colonic cleansing when used in similar regimens. The split-dose preparation is more effective in all agents. SPMC and PEGA are better tolerated than PEG. The preparation regimen and/or the volume do not affect tolerability.
- Klíčová slova
- Ascorbic acid, Colonoscopy, Magnesium citrate, Picosulfate sodium, Polyethylene glycol,
- MeSH
- citráty aplikace a dávkování škodlivé účinky MeSH
- kolonoskopie * MeSH
- kyselina askorbová aplikace a dávkování škodlivé účinky MeSH
- kyselina citronová aplikace a dávkování škodlivé účinky MeSH
- léčebná irigace škodlivé účinky metody MeSH
- lidé MeSH
- organokovové sloučeniny aplikace a dávkování škodlivé účinky MeSH
- pikoliny aplikace a dávkování škodlivé účinky MeSH
- polyethylenglykoly aplikace a dávkování škodlivé účinky MeSH
- projímadla aplikace a dávkování škodlivé účinky MeSH
- prospektivní studie MeSH
- purgativa aplikace a dávkování škodlivé účinky MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
- srovnávací studie MeSH
- Geografické názvy
- Česká republika MeSH
- Názvy látek
- citráty MeSH
- kyselina askorbová MeSH
- kyselina citronová MeSH
- magnesium citrate MeSH Prohlížeč
- MoviPrep MeSH Prohlížeč
- organokovové sloučeniny MeSH
- picosulfate sodium MeSH Prohlížeč
- pikoliny MeSH
- polyethylenglykoly MeSH
- projímadla MeSH
- purgativa MeSH
BACKGROUND AND PURPOSE: Gadobutrol (Gadavist) and gadoteridol (ProHance) have similar macrocyclic molecular structures, but gadobutrol is formulated at a 2-fold higher (1 mol/L versus 0.5 mol/L) concentration. We sought to determine whether this difference impacts morphologic contrast-enhanced MR imaging. MATERIALS AND METHODS: Two hundred twenty-nine adult patients with suspected or known brain tumors underwent two 1.5T MR imaging examinations with gadoteridol or gadobutrol administered in randomized order at a dose of 0.1 mmol/kg of body weight. Imaging sequences and T1 postinjection timing were identical for both examinations. Three blinded readers evaluated images qualitatively and quantitatively for lesion detection and for accuracy in characterization of histologically confirmed brain tumors. Data were analyzed by using the Wilcoxon signed rank test, the McNemar test, and a mixed model. RESULTS: Two hundred nine patients successfully completed both examinations. No reader noted a significant qualitative or quantitative difference in lesion enhancement, extent, delineation, or internal morphology (P values = .69-1.00). One hundred thirty-nine patients had at least 1 histologically confirmed brain lesion. Two readers found no difference in the detection of patients with lesions (133/139 versus 135/139, P = .317; 137/139 versus 136/139, P = .564), while 1 reader found minimal differences in favor of gadoteridol (136/139 versus 132/139, P = .046). Similar findings were noted for the number of lesions detected and characterization of tumors (malignant/benign). Three-reader agreement for characterization was similar for gadobutrol (66.4% [κ = 0.43]) versus gadoteridol (70.3% [κ = 0.45]). There were no significant differences in the incidence of adverse events (P = .199). CONCLUSIONS: Gadoteridol and gadobutrol at 0.1 mmol/kg of body weight provide similar information for visualization and diagnosis of brain lesions. The 2-fold higher gadolinium concentration of gadobutrol provides no benefit for routine morphologic imaging.
- MeSH
- dospělí MeSH
- gadolinium aplikace a dávkování MeSH
- heterocyklické sloučeniny aplikace a dávkování MeSH
- klinické křížové studie MeSH
- kontrastní látky aplikace a dávkování MeSH
- lidé středního věku MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- nádory mozku diagnóza MeSH
- neurozobrazování metody MeSH
- organokovové sloučeniny aplikace a dávkování MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
- Názvy látek
- gadobutrol MeSH Prohlížeč
- gadolinium MeSH
- gadoteridol MeSH Prohlížeč
- heterocyklické sloučeniny MeSH
- kontrastní látky MeSH
- organokovové sloučeniny MeSH
BACKGROUND & AIMS: To compare the efficacy and tolerance of sodium picosulphate/magnesium citrate (PMC) and polyethylene glycol (PEG) in a single or split dose regimen for colonoscopy bowel preparation. METHODS: A prospective, randomized, endoscopist-blinded, multicenter study. The patients were randomly assigned to receive PMC (PMC4/0) or PEG (PEG4/0) in a single dose 4L day before colonoscopy or a split dose 2+2L PMC (PMC2/2) or 3+1L PEG (PEG3/1) one day before and in the morning before the colonoscopy. Each patient was interviewed to determine his/her subjective tolerance of the preparation before the procedure. The quality of bowel cleansing was assessed in a blinded test performed by multiple endoscopists using the Aronchick scale. RESULTS: A total of 600 patients were enrolled, 88.2% were included in the analysis. Satisfactory bowel cleansing (Aronchick score 1 and 2) was significantly more frequent when a split dose was used irrespective of the solution type (81.6% PMC2/2, 87.3% PEG3/1 vs. 73.0% PEG4/0, p = 0.024). In single dose regimens, PMC performed better than PEG (82.6% vs. 73.0%). Single or split dose PMC preparations were comparable. A PMC based solution was generally better tolerated than PEG regardless of the regimen used (p < 0.001). Nausea was reported mostly after the 4L PEG (32.8%, p < 0.001), incontinence after a split PMC dose (34.4%, p = 0.002), and bloating after the 4L PEG (38.0%, p < 0.001). There was no significant difference in the prevalence of vomiting. CONCLUSION: Colonic preparation with PMC yields similar results as a split PEG dose, regardless of whether PMC is administered in single or separate doses. PMC is better tolerated than any PEG-based preparation. A single 4L PEG the day before the colonoscopy is less appropriate for bowel cleansing.
- MeSH
- adherence pacienta MeSH
- citráty aplikace a dávkování škodlivé účinky MeSH
- dospělí MeSH
- fixní kombinace léků MeSH
- jednoduchá slepá metoda MeSH
- kolonoskopie metody MeSH
- kyselina citronová aplikace a dávkování škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- organokovové sloučeniny aplikace a dávkování škodlivé účinky MeSH
- pikoliny aplikace a dávkování škodlivé účinky MeSH
- polyethylenglykoly aplikace a dávkování škodlivé účinky MeSH
- prospektivní studie MeSH
- purgativa aplikace a dávkování škodlivé účinky MeSH
- rozvrh dávkování léků MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
- srovnávací studie MeSH
- Názvy látek
- citráty MeSH
- fixní kombinace léků MeSH
- kyselina citronová MeSH
- magnesium citrate MeSH Prohlížeč
- organokovové sloučeniny MeSH
- picosulfate sodium MeSH Prohlížeč
- pikoliny MeSH
- polyethylenglykoly MeSH
- purgativa MeSH
Faecal excretion is a basic means of detoxification upon ingestion of Pb-contaminated feed. In order to determine a time course of Pb elimination after oral exposure to two different forms of this heavy metal (lead acetate vs. phyto-bound Pb), a feeding study was carried out in experimental rats using the Pb phyto-hyperaccumulator Pistia stratiotes as a model diet. The effect of starvation on Pb excretion was further studied in rats that were fed plant material. Twelve Pb doses (7 μg Pb/1 g BW) were administered orally over a 5-week period. Faeces samples were collected 24 and 72 h post-exposure. Inductively coupled plasma optical emission spectrometry and electrothermal absorption spectrometry methods were used for determination of heavy metal concentrations. Up to 53 % of ingested Pb was rapidly eliminated from the exposed rats via faeces within 24 h after exposure. Faecal excretion in exposed rats differed significantly when compared to that of the control group. Fasting before exposure reduced Pb excretion by up to 50 %. Faecal excretions of both examined Pb forms exhibited almost identical patterns. Considerable differences were revealed concerning total excretion levels; lead acetate was excreted in amount greater extent than those of phytobound Pb. Results of our study suggest that Pb forms occurring in the P. stratiotes tissues are absorbed through the gastrointestinal tract to a greater extent than Pb from lead acetate. Therefore, higher portions of ingested Pb can be available for potential accumulation in tissues of exposed subjects.
- MeSH
- aplikace orální MeSH
- feces chemie MeSH
- krysa rodu Rattus MeSH
- olovo aplikace a dávkování metabolismus MeSH
- organokovové sloučeniny aplikace a dávkování metabolismus MeSH
- potkani Wistar MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- lead acetate MeSH Prohlížeč
- olovo MeSH
- organokovové sloučeniny MeSH